Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Roper Technologies Inc V.ROP.P


Primary Symbol: ROP

Roper Technologies, Inc. is a diversified technology company. The Company operates businesses that design and develop vertical software and technology-enabled products for a variety of defensible niche markets. It operates through three segments: Application Software, Network Software and Technology Enabled Products. The Application Software segment includes Aderant, CBORD, Clinisys, Data Innovations, Deltek, Frontline, IntelliTrans, PowerPlan, Strata and Vertafore. The Network Software segment includes ConstructConnect, DAT, Foundry, iPipeline, iTradeNetwork, Loadlink, MHA, SHP and SoftWriters. The Technology Enabled Products segment includes CIVCO Medical Solutions, FMI, Inovonics, IPA, Neptune, Northern Digital, rf IDEAS and Verathon. Aderant is a comprehensive management software solution for law and other professional services firms. ConstructConnect is a cloud-based data, collaboration, and estimating automation software solutions to a network of pre-construction contractors.


NDAQ:ROP - Post by User

Comment by FreddieMacon Feb 09, 2021 4:37pm
354 Views
Post# 32516742

RE:RE:Bought deal

RE:RE:Bought dealIn simple terms.... 

In a bought deal the company gets the money no matter what, as the underwriters have "bought" the shares and then it is up to them to re-sell them to investors (in other words, go get the stock off their books).   The underwriter takes the risk that they will not be able to re-sell this stock at the Issue Price.  

In a private placement, there is always the risk that there is insufficient investor interest and thus the private placement is not fully subscribed.   So in that scenario the company is taking the financing risk, whereas in a bought deal the underwriters take the financing risk.






jermoguy wrote: Hi, thanks for sending this.  So in layman's terms, a bunch of underwriters bought a block of shares (12.5 mil)  for a discount @ $1.20 a share, with the option to buy more later.  As a result, GDNP gets a $15 million cash infusion.  And then they also paid down debt with BDC, which if memory serves me right, financed them a couple of years ago?  I am sure I have some of this wrong.

I guess the good news is, if these underwriters are buying shares at $1.20, we probably won't be seeing 85 cents again anytime soon.  

Can someone explain the pros and cons of a bought deal over a private placement?

I like the paying down debt part.  


<< Previous
Bullboard Posts
Next >>